O-GlcNAcylation Regulates Phosphorylation of Tau: a Mechanism Involved in Alzheimer's Disease

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Jul 14

PMID 15249677

Citations 320

Authors

Fei Liu

Khalid Iqbal

Inge Grundke-Iqbal

Gerald W Hart

Cheng-Xin Gong

Affiliations

Soon will be listed here.

Abstract

Microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in brains of individuals with Alzheimer's disease (AD) and other tauopathies. Tau pathology is critical to pathogenesis and correlates to the severity of dementia. However, the mechanisms leading to abnormal hyperphosphorylation are unknown. Here, we demonstrate that human brain tau was modified by O-GlcNAcylation, a type of protein O-glycosylation by which the monosaccharide beta-N-acetylglucosamine (GlcNAc) attaches to serine/threonine residues via an O-linked glycosidic bond. O-GlcNAcylation regulated phosphorylation of tau in a site-specific manner both in vitro and in vivo. At most of the phosphorylation sites, O-GlcNAcylation negatively regulated tau phosphorylation. In an animal model of starved mice, low glucose uptake/metabolism that mimicked those observed in AD brain produced a decrease in O-GlcNAcylation and consequent hyperphosphorylation of tau at the majority of the phosphorylation sites. The O-GlcNAcylation level in AD brain extracts was decreased as compared to that in controls. These results reveal a mechanism of regulation of tau phosphorylation and suggest that abnormal hyperphosphorylation of tau could result from decreased tau O-GlcNAcylation, which probably is induced by deficient brain glucose uptake/metabolism in AD and other tauopathies.

Citing Articles

Crosstalk between O-GlcNAcylation and phosphorylation in metabolism: regulation and mechanism.

Zhao Q, Zhou S, Lou W, Qian H, Xu Z Cell Death Differ. 2025; .

PMID: 40045035 DOI: 10.1038/s41418-025-01473-z.

Improving vulnerable Calbindin1 neurons in the ventral hippocampus rescues tau-induced impairment of episodic memory.

Lei H, Lv J, Zhang F, Wei L, Shi K, Liu J Transl Neurodegener. 2025; 14(1):12.

PMID: 40038800 PMC: 11877784. DOI: 10.1186/s40035-025-00473-w.

Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications.

Chen L, Jiang H, Licinio J, Wu H Mol Psychiatry. 2025; .

PMID: 40033044 DOI: 10.1038/s41380-025-02943-z.

Glucose enrichment reduces lifespan and promotes tau phosphorylation in human tau-expressing C. elegans, unaffected by O-β-GlcNAcylation induction.

Ahmad W, Shabbiri K J Mol Med (Berl). 2025; 103(3):327-338.

PMID: 39924618 DOI: 10.1007/s00109-025-02522-3.

Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.

Rojas-Pirela M, Andrade-Alviarez D, Rojas V, Marcos M, Salete-Granado D, Chacon-Arnaude M Open Biol. 2025; 15(2):240239.

PMID: 39904372 PMC: 11793985. DOI: 10.1098/rsob.240239.

References

Gong C, Lidsky T, Wegiel J, Zuck L, Grundke-Iqbal I, Iqbal K . Phosphorylation of microtubule-associated protein tau is regulated by protein phosphatase 2A in mammalian brain. Implications for neurofibrillary degeneration in Alzheimer's disease. J Biol Chem. 2000; 275(8):5535-44. DOI: 10.1074/jbc.275.8.5535. View

Meguro K, Blaizot X, Kondoh Y, Le Mestric C, Baron J, Chavoix C . Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease. Brain. 1999; 122 ( Pt 8):1519-31. DOI: 10.1093/brain/122.8.1519. View

Comer F, Hart G . O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem. 2000; 275(38):29179-82. DOI: 10.1074/jbc.R000010200. View

Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S . Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science. 2000; 290(5500):2302-3. DOI: 10.1126/science.290.5500.2302. View

Gao Y, Wells L, Comer F, Parker G, Hart G . Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem. 2001; 276(13):9838-45. DOI: 10.1074/jbc.M010420200. View

Comer F, Vosseller K, Wells L, Accavitti M, Hart G . Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem. 2001; 293(2):169-77. DOI: 10.1006/abio.2001.5132. View

Lee V, Goedert M, Trojanowski J . Neurodegenerative tauopathies. Annu Rev Neurosci. 2001; 24:1121-59. DOI: 10.1146/annurev.neuro.24.1.1121. View

Planel E, Yasutake K, Fujita S, Ishiguro K . Inhibition of protein phosphatase 2A overrides tau protein kinase I/glycogen synthase kinase 3 beta and cyclin-dependent kinase 5 inhibition and results in tau hyperphosphorylation in the hippocampus of starved mouse. J Biol Chem. 2001; 276(36):34298-306. DOI: 10.1074/jbc.M102780200. View

Niwa K, Kazama K, Younkin S, Carlson G, Iadecola C . Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis. 2002; 9(1):61-8. DOI: 10.1006/nbdi.2001.0460. View

10.

Prapong T, Buss J, Hsu W, Heine P, West Greenlee H, Uemura E . Amyloid beta-peptide decreases neuronal glucose uptake despite causing increase in GLUT3 mRNA transcription and GLUT3 translocation to the plasma membrane. Exp Neurol. 2002; 174(2):253-8. DOI: 10.1006/exnr.2001.7861. View

11.

Ott A, Stolk R, Van Harskamp F, Pols H, Hofman A, Breteler M . Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology. 1999; 53(9):1937-42. DOI: 10.1212/wnl.53.9.1937. View

12.

Xie L, Helmerhorst E, Taddei K, Plewright B, van Bronswijk W, Martins R . Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci. 2002; 22(10):RC221. PMC: 6757630. DOI: 20026383. View

13.

Riley K, Snowdon D, Markesbery W . Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study. Ann Neurol. 2002; 51(5):567-77. DOI: 10.1002/ana.10161. View

14.

Iqbal K, Alonso A, El-Akkad E, Gong C, Haque N, Khatoon S . Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion. J Mol Neurosci. 2002; 19(1-2):95-9. DOI: 10.1007/s12031-002-0017-3. View

15.

Liu F, Iqbal K, Grundke-Iqbal I, Gong C . Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta. FEBS Lett. 2002; 530(1-3):209-14. DOI: 10.1016/s0014-5793(02)03487-7. View

16.

Blaizot X, Meguro K, Millien I, Baron J, Chavoix C, Blaizot A . Correlations between visual recognition memory and neocortical and hippocampal glucose metabolism after bilateral rhinal cortex lesions in the baboon: implications for Alzheimer's disease. J Neurosci. 2002; 22(21):9166-70. PMC: 6758045. View

17.

Liu F, Zaidi T, Iqbal K, Grundke-Iqbal I, Gong C . Aberrant glycosylation modulates phosphorylation of tau by protein kinase A and dephosphorylation of tau by protein phosphatase 2A and 5. Neuroscience. 2002; 115(3):829-37. DOI: 10.1016/s0306-4522(02)00510-9. View

18.

Lefebvre T, Ferreira S, Bussiere T, Delacourte A, Michalski J, Caillet-Boudin M . Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. Biochim Biophys Acta. 2003; 1619(2):167-76. DOI: 10.1016/s0304-4165(02)00477-4. View

19.

Gong C, Liu F, Wu G, Rossie S, Wegiel J, Li L . Dephosphorylation of microtubule-associated protein tau by protein phosphatase 5. J Neurochem. 2003; 88(2):298-310. DOI: 10.1111/j.1471-4159.2004.02147.x. View

20.

Hoyer S . Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol. 2004; 490(1-3):115-25. DOI: 10.1016/j.ejphar.2004.02.049. View